AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163U906.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $903,000 | +314.2% | 961 | +237.2% | 0.00% | – |
| Q2 2020 | $218,000 | +105.7% | 285 | +65.7% | 0.00% | – |
| Q1 2020 | $106,000 | -11.7% | 172 | +73.7% | 0.00% | – |
| Q4 2019 | $120,000 | -28.1% | 99 | -31.7% | 0.00% | – |
| Q3 2019 | $167,000 | -69.2% | 145 | -73.3% | 0.00% | -100.0% |
| Q2 2019 | $542,000 | +721.2% | 543 | +944.2% | 0.00% | – |
| Q1 2019 | $66,000 | +560.0% | 52 | +642.9% | 0.00% | – |
| Q4 2018 | $10,000 | -93.7% | 7 | -91.1% | 0.00% | -100.0% |
| Q3 2018 | $158,000 | -76.0% | 79 | -76.6% | 0.00% | -66.7% |
| Q2 2018 | $657,000 | – | 337 | +6640.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 5 | -99.2% | 0.00% | -100.0% |
| Q4 2017 | $29,000 | +866.7% | 664 | +681.2% | 0.00% | – |
| Q3 2017 | $3,000 | -50.0% | 85 | -38.4% | 0.00% | – |
| Q2 2017 | $6,000 | +20.0% | 138 | +220.9% | 0.00% | – |
| Q1 2017 | $5,000 | -85.3% | 43 | -21.8% | 0.00% | -100.0% |
| Q4 2016 | $34,000 | +3300.0% | 55 | +511.1% | 0.00% | – |
| Q3 2016 | $1,000 | -85.7% | 9 | -79.5% | 0.00% | – |
| Q2 2016 | $7,000 | -22.2% | 44 | -38.0% | 0.00% | -100.0% |
| Q1 2016 | $9,000 | +28.6% | 71 | +610.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | +600.0% | 10 | -65.5% | 0.00% | – |
| Q3 2015 | $1,000 | -98.1% | 29 | -65.1% | 0.00% | -100.0% |
| Q2 2015 | $53,000 | +103.8% | 83 | +97.6% | 0.00% | +33.3% |
| Q1 2015 | $26,000 | -58.1% | 42 | -58.0% | 0.00% | -62.5% |
| Q4 2014 | $62,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|